Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Blueprint Medicines Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 264 | 1 | 281 | +18 |
| Shares | 58.5M | 3.23K | 58.5M | −22.8K (0.0%) |
| Value | $5.69B | $314.0K | $5.14B | −$547.9M (−9.6%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (54)
Institutions that held Blueprint Medicines Corp at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (36)
Institutions that held Blueprint Medicines Corp at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (1)
Institutions that held Blueprint Medicines Corp at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 3,231 | $314.0K |